G1 THERAPEUTICS, INC. — Operating Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/11ffe688-c303-44c4-b8b5-aa7630bb240f/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-39.5M | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-007601 |
| FY 2022 | $-136.2M | 2022-01-01 – 2022-12-31 | evidence 0001628280-23-005853 |
| FY 2021 | $-142.5M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-006299 |
| FY 2020 | $-96.5M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-008171 |
| FY 2019 | $-129.0M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-006846 |
| FY 2018 | $-89.3M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-005520 |
| FY 2017 | $-61.0M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-002706 |
| FY 2016 | $-30.4M | 2016-01-01 – 2016-12-31 | evidence 0001564590-18-002706 |
| FY 2015 | $-15.4M | 2015-01-01 – 2015-12-31 | evidence 0001564590-18-002706 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).